KNCV Tuberculosis Foundation

21/10/2026

📢SAVE THE DATE📢
Under the Unitaid-funded ASCENT DR-TB project, active Drug Safety Monitoring and Management ( ) has been a key intervention supporting the safe implementation of new DR-TB treatment regimens. ASCENT DR-TB partners have worked to:
📌strengthen healthcare worker capacity through training and mentorship,
📌improve adverse event detection, management and reporting,
📌strengthen pharmacovigilance systems, and
📌foster collaboration between TB programs and regulatory authorities.

Join us for a cross-country knowledge exchange exploring practical experiences and lessons from Indonesia and Vietnam on strengthening patient safety and improving the quality of DR-TB care.
📆28 October
🕛12:00 - 14:00 CET (Amsterdam time)

Why attend?
💊To understand the role of aDSM in the implementation of new DR-TB drugs and regimens.
💊To strengthen your understanding of adverse event detection, grading, management, recording and reporting.
💊To explore ways to improve coordination between TB and pharmacovigilance systems.
💊To learn from practical experiences and lessons from ASCENT DR-TB implementation in Indonesia and Vietnam.

🔗Register now: 2e899e1b-7933-46e8-a068-0e55cdef6e72@f28ee6e5-b8a6-48c5-89d0-aaeef9ebd92e" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/2e899e1b-7933-46e8-a068-0e55cdef6e72@f28ee6e5-b8a6-48c5-89d0-aaeef9ebd92e

20/10/2026

How can TB elimination be achieved in high TB-burden settings?🤔

Our colleague and (TB) expert Degu Jerene will be joining the with answers to this question, and more questions to be asked:
✍How can these approaches be sustainable?
✍How can communities play a role in these strategies?
✍How can we adapt these initiatives across different high TB-burden settings?

Interested in knowing more? Find us at The Union World Conference on Lung Health 2026 in Rio, talk to us and build partnerships to achieving TB elimination in our lifetime.

See you in Rio!

📚KNCV at the Union Conference 2026: https://www.kncvtbplus.com/kncv-union-conference-2026
International Union Against Tuberculosis and Lung Disease (The Union)

19/10/2026

SIILTIBCY test implementation and prospects for its continued use in the Republic of Tajikistan📌

On October 9, 2026, a consultative meeting was held in Dushanbe city, attended by representatives from the Dushanbe City’s TB Center, KNCV in Tajikistan, and healthcare professionals involved in the research project on introduction and use of test.

Between June 5 and September 30, 2026, 254 contact individuals underwent testing using the SIILTIBCY method*:
🔹46 people tested positive
🔹8 confirmed cases of TB
🔹26 contact individuals started preventive treatment
*All those tested also underwent an X-ray examination.

💪The significance of this research project is the opportunity to assess the practical SILTIBCY implementation taking into account the conditions of health care in Tajikistan. 🔗Read more about it here:

On October 9, 2026, a consultative meeting was held in Dushanbe city, attended by representatives from the Dushanbe City’s TB Center, KNCV in Tajikistan, and healthcare professionals involved in the research project on introduction and use of SIILTIBCY test.

16/10/2026

Did you know that as part of our knowledge exchange approaches we record all of our webinar sessions and make them publicly available for further consultation?🤔💻

Earlier this week we held a webinar to learn from practical experiences across the Philippines and Ukraine and explore how policy support, capacity strengthening, community engagement, multisectoral collaboration and market-shaping approaches can contribute to better TB prevention, diagnosis and care.

‼️How important it is to have stakeholders sit together, present and reflect on how approaches are taken up across sectors: departments of health, community-led organizations, CSOs and market access.

This webinar was conducted under the Unitaid-funded projet ASCENT DR-TB. We thank speakers and moderators from the Department of Health of the Philippines, KNCV Ethiopia, KNCV Philippines, PATH, TBpeopleUkraine and Clinton Health Access Initiative. 🤝

👀Watch the recording here: https://www.youtube.com/watch?v=BtuGjCAKQrk
📌Learn more here: https://www.kncvtbplus.com/articles/webinars/policy-impact-advancing-dr-tb-prevention-diagnosis-and-access-through-community

Across ASCENT DR-TB partner countries and technical partners, impor...

13/10/2026

Looking back at the ASCENT DR-TB dissemination workshop in Mozambique💫

The session brought together local leaders and stakeholders to discuss the critical role of active drug safety monitoring and management ( ) in ensuring safe, effective, and people-centered care for individuals on treatment for (DR-TB).

‼️Patient safety is essential for the successful introduction of new medicines and shorter DR-TB treatment regimens. Strengthening safety monitoring through collaboration between the pharmacovigilance unit, healthcare providers, affected communities, and partners has created the conditions for scale-up and fostered a more inclusive, people-centered approach to care.🤝

By working together, is enhancing aDSM, improving treatment outcomes, and ensuring that innovation in TB care is matched by strong systems to protect and support patients every step of their treatment journey.💪

ASCENT DR-TB is a Unitaid -funded project led by KNCV. Learn more at www.ascentdrtb.org

12/10/2026

Across ASCENT DR-TB partner countries and technical partners, important progress has been made in strengthening people-centred prevention, diagnosis and care for drug-resistant (DR-TB). How has this been achieved?🤔
🔹Learn from the ’ experience in developing policies and guidelines to scale up DR-TB preventive treatment and diagnostic innovations.
🔹Discover how community-led TB care and are strengthening prevention, screening, referral and support in .
🔹Gain insights into efforts to improve access to TB commodities and address procurement and supply-chain barriers.

Join us this Wednesday for the webinar "From policy to impact: Advancing DR-TB prevention, diagnosis and access through community and market solutions"

📆14 of October, 2026
12:00 - 14:00 CET (Amsterdam time)

Chaired by experts Dr Ahmed Bedru (KNCV Ethiopia) and Dr. Elzier Mavume-Mangunyane (The Aurum Institute), this webinar will bring Dr. Charisse Malbacias, Dr. Mamel Quelapio, Ms. Leveriza Coprada, RMT, MPH, Mr. Volodymyr Kochanov, Olya Klymenko and Swarnika Ahuja to explore how policies, community-led approaches and access strategies can translate into meaningful improvements for people affected by TB.

👉Register now: e259bfd9-3a77-45a7-9f7a-c4420b8228a6@f28ee6e5-b8a6-48c5-89d0-aaeef9ebd92e" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/e259bfd9-3a77-45a7-9f7a-c4420b8228a6@f28ee6e5-b8a6-48c5-89d0-aaeef9ebd92e
📌Learn more: https://www.kncvtbplus.com/articles/webinars/policy-impact-advancing-dr-tb-prevention-diagnosis-and-access-through-community

This webinar is part of the Unitaid-funded project ASCENT DR-TB led by KNCV Tuberculosefonds

PATH | Clinton Health Access Initiative | CO TBPeople Ukraine

05/10/2026

Join us this November at the where our colleague Dr. Cecile Magis-Escurra will be chairing the working group of in prisons.

👉Prisons are not islands and are certainly not isolated from society. The high rates of TB among people in settings drive up TB incidence in the general population, making it clear that “no one is safe until everyone is safe.” The health of people deprived of liberty is a public health concern that affects us all.

TB remains a global health threat, and an urgent focus on prison settings is necessary. See you in Rio!

📚Read more about TB in prisons and find our program at the The Union World Conference on Lung Health at kncvtbplus.com

02/10/2026

Emerging and re-emerging infectious diseases continue to pose significant health, social, and economic challenges across Sub-Saharan Africa. Outbreaks such as ebola, Mpox, COVID-19, and other epidemic-prone diseases highlight the need for strong health systems that can anticipate risks and guide timely responses.💻

👉The TIMERA (Training Initiative for Modelling Epidemic Response in Africa) project is strengthening Africa’s capacity to use infectious disease modelling to better prepare for, detect, and respond to disease outbreaks. aims to support faster, more effective, and locally driven public health decision-making across sub-Saharan Africa by building a new generation of African modelling experts.

💪The project is organising short-term, combined training programmes for early- to mid-career researchers and public health professionals with a strong commitment to apply modelling approaches in infectious disease control. In total, it will train 50 African fellows, adding significantly to the regional epidemiological workforce.

📢The Call for applications for Short-Term Training Fellowship is open until October 15, 2026. Apply now: https://docs.google.com/forms/d/e/1FAIpQLSfISlfdvJv-q-mpSal6lmXsSdjZ6bX_bFOQBneZ5AxVbMIubw/viewform‼️

📌Learn more about TIMERA: https://www.edctp.org/news/developing-africas-next-generation-of-epidemic-modellers-through-timera/

This project is possible with financial support from the Global Health , co-funded by the .

Addis Ababa University | Reseau Africain de Recherche en Sante | Universidade Eduardo Mondlane | Radboudumc

01/10/2026

The Union Conference 2026 is fast approaching👟
Best practice sharing and knowledge exchange are key for scaling-up innovative approaches to ending TB.

🤝Dr. Gidado Mustapha, executive director of KNCV Tuberculosefonds will attend the and participate in relevant conversations at the Summit by World Health Organization (WHO) and the 4th Annual New Tools Summit by Stop TB Partnership Working Groups!

See you in Rio!

International Union Against Tuberculosis and Lung Disease (The Union) | The Union World Conference on Lung Health

29/09/2026

Ensuring patient safety through the Unitaid-funded ASCENT DR-TB project💊

Earlier this month, our colleague Mansa Mbenga had the opportunity to engage with healthcare professionals in and discuss key challenges in (AE) detection, management, recording, and reporting. Interactive case reviews and experience sharing helped them explore practical approaches to identifying, managing, and documenting AEs to enhance patient safety and quality of care.

Yes, effective implementation of shorter all-oral treatment regimens leads to better treatment outcomes. But also, implementing strong active drug monitoring and management (aDSM) practices has a key role in ensuring patient safety throughout the treatment journey.🛣️

👉Read more about the project at www.ascentdrtb.org

The Aurum Institute